Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Non-Current Deffered Revenue: 2012-2024

Historic Non-Current Deffered Revenue for Lifecore Biomedical (LFCR) over the last 3 years, with May 2024 value amounting to $4.7 million.

  • Lifecore Biomedical's Non-Current Deffered Revenue rose 1420.25% to $4.9 million in Q4 2024 from the same period last year, while for Nov 2024 it was $4.9 million, marking a year-over-year increase of 1420.25%. This contributed to the annual value of $4.7 million for FY2024, which is 59.97% up from last year.
  • As of FY2024, Lifecore Biomedical's Non-Current Deffered Revenue stood at $4.7 million, which was up 59.97% from $2.9 million recorded in FY2023.
  • In the past 5 years, Lifecore Biomedical's Non-Current Deffered Revenue registered a high of $4.7 million during FY2024, and its lowest value of $2.9 million during FY2023.
  • In the last 2 years, Lifecore Biomedical's Non-Current Deffered Revenue had a median value of $3.8 million in 2023 and averaged $3.8 million.
  • Data for Lifecore Biomedical's Non-Current Deffered Revenue shows a peak YoY spiked of 59.97% (in 2024) over the last 5 years.
  • Over the past 2 years, Lifecore Biomedical's Non-Current Deffered Revenue (Yearly) stood at $2.9 million in 2023, then skyrocketed by 59.97% to $4.7 million in 2024.